{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:58:57Z","timestamp":1773813537623,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX10732202"],"award-info":[{"award-number":["2018ZX10732202"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Postgraduate scientific research innovation project of Chongqing, China","award":["CYB18164"],"award-info":[{"award-number":["CYB18164"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s13402-020-00540-6","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T17:03:04Z","timestamp":1603386184000},"page":"931-947","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["LINC01419 promotes cell proliferation and metastasis in hepatocellular carcinoma by enhancing NDRG1 promoter activity"],"prefix":"10.1007","volume":"43","author":[{"given":"Hao","family":"Dang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenlu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renfei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ailong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5757-4123","authenticated-orcid":false,"given":"Hua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,15]]},"reference":[{"key":"540_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"F. Bray, J. Ferlay, I. Soerjomataram, R.L. Siegel, L.A. Torre, A. Jemal, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018)","journal-title":"CA Cancer J. Clin."},{"key":"540_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"R.L. Siegel, K.D. Miller, A. Jemal, Cancer statistics, 2017. CA Cancer J. Clin. 67, 7\u201330 (2017)","journal-title":"CA Cancer J. Clin."},{"key":"540_CR3","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"A. Forner, M. Reig, J. Bruix, Hepatocellular carcinoma. Lancet 391, 1301\u20131314 (2018)","journal-title":"Lancet"},{"key":"540_CR4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"PR Galle","year":"2018","unstructured":"P.R. Galle, A. Forner, J.M. Llovet, V. Mazzaferro, F. Piscaglia, J.L. Raoul, P. Schirmacher, V. Vilgrain, EASL clinical practice guidelines: Management of hepatocellular carcinoma. J. Hepatol. 69, 182\u2013236 (2018)","journal-title":"J. Hepatol."},{"key":"540_CR5","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.jhep.2016.05.035","volume":"65","author":"K Schulze","year":"2016","unstructured":"K. Schulze, J.C. Nault, A. Villanueva, Genetic profiling of hepatocellular carcinoma using next-generation sequencing. J. Hepatol. 65, 1031\u20131042 (2016)","journal-title":"J. Hepatol."},{"key":"540_CR6","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1136\/gutjnl-2018-316408","volume":"68","author":"R Pinyol","year":"2019","unstructured":"R. Pinyol, R. Montal, L. Bassaganyas, D. Sia, T. Takayama, G.Y. Chau, V. Mazzaferro, S. Roayaie, H.C. Lee, N. Kokudo, Z. Zhang, S. Torrecilla, A. Moeini, L. Rodriguez-Carunchio, E. Gane, C. Verslype, A.E. Croitoru, U. Cillo, M. de la Mata, L. Lupo, S. Strasser, J.W. Park, J. Camps, M. Sol\u00e9, S.N. Thung, A. Villanueva, C. Pena, G. Meinhardt, J. Bruix, J.M. Llovet, Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial. Gut 68, 1065\u20131075 (2019)","journal-title":"Gut"},{"key":"540_CR7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s13402-019-00432-4","volume":"42","author":"X Zhou","year":"2019","unstructured":"X. Zhou, A. Zhu, X. Gu, G. Xie, Inhibition of MEK suppresses hepatocellular carcinoma growth through independent MYC and BIM regulation. Cell. Oncol. 42, 369\u2013380 (2019)","journal-title":"Cell. Oncol."},{"key":"540_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13402-018-0407-3","volume":"42","author":"KR Zahid","year":"2019","unstructured":"K.R. Zahid, S. Han, F. Zhou, U. Raza, Novel tumor suppressor SPRYD4 inhibits tumor progression in hepatocellular carcinoma by inducing apoptotic cell death. Cell. Oncol. 42, 55\u201366 (2019)","journal-title":"Cell. Oncol."},{"key":"540_CR9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","volume":"172","author":"F Kopp","year":"2018","unstructured":"F. Kopp, J.T. Mendell, Functional classification and experimental dissection of long noncoding RNAs. Cell 172, 393\u2013407 (2018)","journal-title":"Cell"},{"key":"540_CR10","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jhep.2017.04.009","volume":"67","author":"M Klingenberg","year":"2017","unstructured":"M. Klingenberg, A. Matsuda, S. Diederichs, T. Patel, Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets. J. Hepatol. 67, 603\u2013618 (2017)","journal-title":"J. Hepatol."},{"key":"540_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.pharmthera.2016.03.004","volume":"161","author":"MA Parasramka","year":"2016","unstructured":"M.A. Parasramka, S. Maji, A. Matsuda, I.K. Yan, T. Patel, Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma. Pharmacol. Ther. 161, 67\u201378 (2016)","journal-title":"Pharmacol. Ther."},{"key":"540_CR12","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s13402-018-0406-4","volume":"41","author":"R Castro-Oropeza","year":"2018","unstructured":"R. Castro-Oropeza, J. Melendez-Zajgla, V. Maldonado, K. Vazquez-Santillan, The emerging role of lncRNAs in the regulation of cancer stem cells. Cell. Oncol. 41, 585\u2013603 (2018)","journal-title":"Cell. Oncol."},{"key":"540_CR13","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","volume":"29","author":"AM Schmitt","year":"2016","unstructured":"A.M. Schmitt, H.Y. Chang, Long noncoding RNAs in cancer pathways. Cancer Cell 29, 452\u2013463 (2016)","journal-title":"Cancer Cell"},{"key":"540_CR14","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/hep.29209","volume":"66","author":"Y Song","year":"2017","unstructured":"Y. Song, C. Liu, X. Liu, J. Trottier, M. Beaudoin, L. Zhang, C. Pope, G. Peng, O. Barbier, X. Zhong, L. Li, L. Wang, H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of epithelial cell adhesion molecule. Hepatology 66, 1183\u20131196 (2017)","journal-title":"Hepatology"},{"key":"540_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s13402-019-00478-4","volume":"43","author":"N Zhang","year":"2020","unstructured":"N. Zhang, X. Chen, A positive feedback loop involving the LINC00346\/\u03b2-catenin\/MYC axis promotes hepatocellular carcinoma development. Cell. Oncol. 43, 137\u2013153 (2020)","journal-title":"Cell. Oncol."},{"key":"540_CR16","doi-asserted-by":"publisher","first-page":"12598","DOI":"10.1038\/ncomms12598","volume":"7","author":"ZZ Chen","year":"2016","unstructured":"Z.Z. Chen, L. Huang, Y.H. Wu, W.J. Zhai, P.P. Zhu, Y.F. Gao, LncSox4 promotes the self-renewal of liver tumour-initiating cells through Stat3-mediated Sox4 expression. Nat. Commun. 7, 12598 (2016)","journal-title":"Nat. Commun."},{"key":"540_CR17","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1038\/s41467-018-04006-0","volume":"9","author":"Z Li","year":"2018","unstructured":"Z. Li, J. Zhang, X. Liu, S. Li, Q. Wang, C. Di, Z. Hu, T. Yu, J. Ding, J. Li, M. Yao, J. Fan, S. Huang, Q. Gao, Y. Zhao, X. He, The LINC01138 drives malignancies via activating arginine methyltransferase 5 in hepatocellular carcinoma. Nat. Commun. 9, 1572 (2018)","journal-title":"Nat. Commun."},{"key":"540_CR18","doi-asserted-by":"crossref","unstructured":"Y.L. Wang, J.Y. Liu, J.E. Yang, X.M. Yu, Z.L. Chen, Y.J. Chen, M. Kuang, Y. Zhu, S.M. Zhuang, Lnc-UCID promotes G1\/S transition and hepatoma growth by preventing DHX9-mediated CDK6 down-regulation. Hepatology 70, 259\u2013275 (2019)","DOI":"10.1002\/hep.30613"},{"key":"540_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/hep.29405","volume":"67","author":"J Zhang","year":"2018","unstructured":"J. Zhang, Z. Li, L. Liu, Q. Wang, S. Li, D. Chen, Z. Hu, T. Yu, J. Ding, J. Li, M. Yao, S. Huang, Y. Zhao, X. He, Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin-6\/STAT3 signaling pathway. Hepatology 67, 171\u2013187 (2018)","journal-title":"Hepatology"},{"key":"540_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrgastro.2017.169","volume":"15","author":"CM Wong","year":"2018","unstructured":"C.M. Wong, F.H. Tsang, I.O. Ng, Non-coding RNAs in hepatocellular carcinoma: Molecular functions and pathological implications. Nat. Rev. Gastroenterol. Hepatol. 15, 137\u2013151 (2018)","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"540_CR21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.stem.2015.03.003","volume":"16","author":"Y Wang","year":"2015","unstructured":"Y. Wang, L. He, Y. Du, P. Zhu, G. Huang, J. Luo, X. Yan, B. Ye, C. Li, P. Xia, G. Zhang, Y. Tian, R. Chen, Z. Fan, The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling. Cell Stem Cell 16, 413\u2013425 (2015)","journal-title":"Cell Stem Cell"},{"key":"540_CR22","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/hep.27893","volume":"63","author":"SX Yuan","year":"2016","unstructured":"S.X. Yuan, J. Wang, F. Yang, Q.F. Tao, J. Zhang, L.L. Wang, Y. Yang, H. Liu, Z.G. Wang, Q.G. Xu, J. Fan, L. Liu, S.H. Sun, W.P. Zhou, Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1. Hepatology 63, 499\u2013511 (2016)","journal-title":"Hepatology"},{"key":"540_CR23","doi-asserted-by":"publisher","first-page":"95799","DOI":"10.18632\/oncotarget.21329","volume":"8","author":"M Dai","year":"2017","unstructured":"M. Dai, S. Chen, X. Wei, X. Zhu, F. Lan, S. Dai, X. Qin, Diagnosis, prognosis and bioinformatics analysis of lncRNAs in hepatocellular carcinoma. Oncotarget 8, 95799\u201395809 (2017)","journal-title":"Oncotarget"},{"key":"540_CR24","doi-asserted-by":"publisher","first-page":"43770","DOI":"10.18632\/oncotarget.6087","volume":"6","author":"H Zhang","year":"2015","unstructured":"H. Zhang, C. Zhu, Y. Zhao, M. Li, L. Wu, X. Yang, X. Wan, A. Wang, M.Q. Zhang, X. Sang, H. Zhao, Long non-coding RNA expression profiles of hepatitis C virus-related dysplasia and hepatocellular carcinoma. Oncotarget 6, 43770\u201343778 (2015)","journal-title":"Oncotarget"},{"key":"540_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.canlet.2011.06.001","volume":"310","author":"J Cheng","year":"2011","unstructured":"J. Cheng, H.Y. Xie, X. Xu, J. Wu, X. Wei, R. Su, W. Zhang, Z. Lv, S. Zheng, L. Zhou, NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma. Cancer Lett. 310, 35\u201345 (2011)","journal-title":"Cancer Lett."},{"key":"540_CR26","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/carcin\/bgt401","volume":"35","author":"WJ Lu","year":"2014","unstructured":"W.J. Lu, M.S. Chua, S.K. So, Suppressing N-Myc downstream regulated gene 1 reactivates senescence signaling and inhibits tumor growth in hepatocellular carcinoma. Carcinogenesis 35, 915\u2013922 (2014)","journal-title":"Carcinogenesis"},{"key":"540_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.canlet.2017.12.021","volume":"417","author":"Q Luo","year":"2018","unstructured":"Q. Luo, C.Q. Wang, L.Y. Yang, X.M. Gao, H.T. Sun, Y. Zhang, K.L. Zhang, Y. Zhu, Y. Zheng, Y.Y. Sheng, L. Lu, H.L. Jia, W.Q. Yu, J. Liu, Q.Z. Dong, L.X. Qin, FOXQ1\/NDRG1 axis exacerbates hepatocellular carcinoma initiation via enhancing crosstalk between fibroblasts and tumor cells. Cancer Lett. 417, 21\u201334 (2018)","journal-title":"Cancer Lett."},{"key":"540_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.yexcr.2019.03.029","volume":"379","author":"Y Liu","year":"2019","unstructured":"Y. Liu, D. Wang, Y. Li, S. Yan, H. Dang, H. Yue, J. Ling, F. Chen, Y. Zhao, L. Gou, P. Tang, A. Huang, H. Tang, Long noncoding RNA CCAT2 promotes hepatocellular carcinoma proliferation and metastasis through up-regulation of NDRG1. Exp. Cell Res. 379, 19\u201329 (2019)","journal-title":"Exp. Cell Res."},{"key":"540_CR29","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1136\/jclinpath-2013-201692","volume":"66","author":"DH Bae","year":"2013","unstructured":"D.H. Bae, P.J. Jansson, M.L. Huang, Z. Kovacevic, D. Kalinowski, C.S. Lee, S. Sahni, D.R. Richardson, The role of NDRG1 in the pathology and potential treatment of human cancers. J. Clin. Pathol. 66, 911\u2013917 (2013)","journal-title":"J. Clin. Pathol."},{"key":"540_CR30","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.1158\/0008-5472.CAN-08-4882","volume":"69","author":"F Hosoi","year":"2009","unstructured":"F. Hosoi, H. Izumi, A. Kawahara, Y. Murakami, H. Kinoshita, M. Kage, K. Nishio, K. Kohno, M. Kuwano, M. Ono, N-myc downstream regulated gene 1\/Cap43 suppresses tumor growth and angiogenesis of pancreatic cancer through attenuation of inhibitor of kappaB kinase beta expression. Cancer Res. 69, 4983\u20134991 (2009)","journal-title":"Cancer Res."},{"key":"540_CR31","doi-asserted-by":"publisher","first-page":"25025","DOI":"10.1074\/jbc.M113.472068","volume":"288","author":"Y Murakami","year":"2013","unstructured":"Y. Murakami, K. Watari, T. Shibata, M. Uba, H. Ureshino, A. Kawahara, H. Abe, H. Izumi, N. Mukaida, M. Kuwano, M. Ono, N-myc downstream-regulated gene 1 promotes tumor inflammatory angiogenesis through JNK activation and autocrine loop of interleukin-1\u03b1 by human gastric cancer cells. J. Biol. Chem. 288, 25025\u201325037 (2013)","journal-title":"J. Biol. Chem."},{"key":"540_CR32","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.3892\/ol.2013.1636","volume":"6","author":"Y Song","year":"2013","unstructured":"Y. Song, L. Cao, N-myc downstream-regulated gene 1: Diverse and complicated functions in human hepatocellular carcinoma (review). Oncol. Lett. 6, 1539\u20131542 (2013)","journal-title":"Oncol. Lett."},{"key":"540_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2010.05.020","volume":"298","author":"EU Jung","year":"2010","unstructured":"E.U. Jung, J.H. Yoon, Y.J. Lee, J.H. Lee, B.H. Kim, S.J. Yu, S.J. Myung, Y.J. Kim, H.S. Lee, Hypoxia and retinoic acid-inducible NDRG1 expression is responsible for doxorubicin and retinoic acid resistance in hepatocellular carcinoma cells. Cancer Lett. 298, 9\u201315 (2010)","journal-title":"Cancer Lett."},{"key":"540_CR34","doi-asserted-by":"crossref","unstructured":"Q. Chen, D. Wang, Y. Li, S. Yan, H. Dang, H. Yue, J. Ling, F. Chen, Y. Zhao, L. Gou, P. Tang, A. Huang, H. Tang, LINC00628 suppresses migration and invasion of hepatocellular carcinoma by its conserved region interacting with the promoter of VEGFA. J. Cell. Physiol. 1\u201312 (2019)","DOI":"10.1002\/jcp.28233"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-020-00540-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-020-00540-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-020-00540-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T23:06:11Z","timestamp":1623711971000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-020-00540-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,15]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["540"],"URL":"https:\/\/doi.org\/10.1007\/s13402-020-00540-6","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,15]]},"assertion":[{"value":"5 June 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the ethics committee of the Third Hospital of Mianyang, and informed consent was obtained from each patient. Animal studies were approved by the Ethics Committee of Animal Experiments of Chongqing Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}